tiprankstipranks
Advertisement
Advertisement
RxSight, Alcon Partner on Light-Adjustable Cataract Lenses
PremiumCompany AnnouncementsRxSight, Alcon Partner on Light-Adjustable Cataract Lenses
5d ago
Alcon, RxSight enter non-exclusive pact to develop adjustable PCIOLs
Premium
The Fly
Alcon, RxSight enter non-exclusive pact to develop adjustable PCIOLs
5d ago
Alcon, RxSight announce collaboration to develop adjustable PCIOLs
Premium
The Fly
Alcon, RxSight announce collaboration to develop adjustable PCIOLs
5d ago
RxSight reports Q1 adjusted EPS (19c), consensus (15c)
PremiumThe FlyRxSight reports Q1 adjusted EPS (19c), consensus (15c)
2M ago
RxSight backs FY26 revenue view $120M-$135M, consensus $129.22M
Premium
The Fly
RxSight backs FY26 revenue view $120M-$135M, consensus $129.22M
2M ago
William Blair med tech analyst holds an analyst/industry conference call
Premium
The Fly
William Blair med tech analyst holds an analyst/industry conference call
3M ago
RxSight reports Q4 EPS (3c), consensus (20c)
PremiumThe FlyRxSight reports Q4 EPS (3c), consensus (20c)
5M ago
RxSight sees FY26 revenue $120M-$135M, consensus $135.34M
Premium
The Fly
RxSight sees FY26 revenue $120M-$135M, consensus $135.34M
5M ago
RXST Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RXST Upcoming Earnings Report: What to Expect?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100